Review: How Vitamin D Supplementation Improve Insulin Sensitivity in Patients with Metabolic Syndrome
Vitamin D Supplementation
DOI:
https://doi.org/10.55544/jrasb.2.3.21Keywords:
Vitamin D, Diabetes mellitus, PCOS (Polycystic Ovary Syndrome), insulin, obesityAbstract
The metabolic syndrome is a group of cardio metabolic risk factors characterized by adipose tissue malfunction and insulin resistance. Insulin resistance might be one of the main reasons of many metabolic disturbances as well as dysregulation of the blood glucose level. In recent years, the relationship between vitamin D and insulin resistance has been a topic of debate and growing broad interest. In fact, vitamin D serum level may be one of the factors accelerating the development of insulin resistance. Vitamin D deficiency is a common abnormal condition in the population and may be involved with the pathogenesis of diseases related to insulin resistance, such as obesity, diabetes, hyperlipidemia and polycystic ovary syndrome (PCOS). In addition, there are several researches that recommended the use of vitamin D to improve insulin resistance in patients with metabolic disorders, but the mechanism by which the vitamin works to produce this effect is still a matter of debate among researchers. the aim of this review is to summarize the recent evidence suggest mechanisms by which vitamin D can improves insulin sensitivity.
Downloads
Metrics
References
Maretzke, F.; Bechthold, A.; Egert, S.; Ernst, J.B.; van Lent, D.M.; Pilz, S.; Reichrath, J.; Stangl, G.I.; Stehle, P.; Volkert, D.; et al. Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases—An Umbrella Review. Nutrients 2020, 12, 969.
Pike, J.W.; Meyer, M.B. The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D(3). Endocrinol. Metab. Clin. N. Am. 2010, 39, 255–269.
Parsanathan, R.; Jain, S.K. Glutathione Deficiency Alters the Vitamin D-Metabolizing Enzymes CYP27B1 and CYP24A1 in Human Renal Proximal Tubule Epithelial Cells and Kidney of HFD-Fed Mice. Free Radic. Biol. Med. 2019, 131, 376–381. [CrossRef]
Jamilian, M.; Samimi, M.; Ebrahimi, F.A.; Hashemi, T.; Taghizadeh, M.; Razavi, M.; Sanami, M.; Asemi, Z. The Effects of Vitamin D and Omega-3 Fatty Acid Co-Supplementation on Glycemic Control and Lipid Concentrations in Patients with Gestational Diabetes. J. Clin. Lipidol. 2017, 11, 459–468. [Google Scholar] [CrossRef] [PubMed]
Imga, N.N.; Karci, A.C.; Oztas, D.; Berker, D.; Guler, S. Effects of Vitamin D Supplementation on Insulin Resistance and Dyslipidemia in Overweight and Obese Premenopausal Women. Arch. Med. Sci. AMS 2019, 15, 598–606. [Google Scholar] [CrossRef] [PubMed]
Sizar, O.; Khare, S.; Goyal, A.; Givler, A. Vitamin D Deficiency; StatPearls: Treaure Island, Finland, 2022
Victoria C. Bolívar ,Beatriz G.Fontana ,Cristina G.Fontana and Manuel M.Torres. Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice. Nutrients 2021, 13(10), 3491
Barbarawi, M.; Zayed, Y.; Barbarawi, O.; Bala, A.; Alabdouh, A.; Gakhal, I.; Rizk, F.; Alkasasbeh, M.; Bachuwa, G.; Manson, J.E. Effect of Vitamin D Supplementation on the Incidence of Diabetes Mellitus. J. Clin. Endocrinol. Metab. 2020, 105, dgaa335. [CrossRef] [PubMed]
Liu, E.; Meigs, J.B.; Pittas, A.G.; McKeown, N.M.; Economos, C.D.; Booth, S.L.; Jacques, P.F. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J. Nutr. 2009, 139, 329–334. [CrossRef] [PubMed]
Dipanshu S, Chakravorty R. The relationship between vitamin D, insulin resistance and infertility in PCOS women. Gynecol Obs. 2015;5(294):932–2161.
Kiyak Caglayan E, Engin-Üstun Y, Sari N, Göçmen AY, Seckin L, Kara M, et al. Is there association between vitamin D levels, apelin 36, and visfatin in PCOS? Gynecol Endocrinol. 2016;32(5):386–9.
Monastra, G.; De Grazia, S.; De Luca, L.; Vittorio, S.; Unfer, V. Vitamin D: A Steroid Hormone with Progesterone-like Activity. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 2502–2512. [Google Scholar] [CrossRef]
Hammond, G.L. Plasma Steroid-Binding Proteins: Primary Gatekeepers of Steroid Hormone Action. J. Endocrinol. 2016, 230, R13–R25. [Google Scholar] [CrossRef] [PubMed][Green Version]
Li, Y.; Wang, J.; Yang, J.; Chen, J.; Zhou, W.; Qiao, C.; Shen, S.; Bi, Y. The Correlation between Vitamin D, Glucose Homeostasis and Androgen Level among Polycystic Ovary Syndrome Patients: A Cross-Sectional Study. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 2021, 37, 235–239. [Google Scholar] [CrossRef]
Ostadmohammadi, V.; Milajerdi, A.; Ghayour-Mobarhan, M.; Ferns, G.; Taghizadeh, M.; Badehnoosh, B.; Mirzaei, H.; Asemi, Z. The Effects of Vitamin D Supplementation on Glycemic Control, Lipid Profiles and C-Reactive Protein Among Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr. Pharm. Des. 2019, 25, 201–210. [CrossRef] [PubMed]
James C. Fleet. The role of vitamin D in the endocrinology controlling calcium homeostasis. Molecular and Cellular Endocrinology.2017. Volume 453, Pages 36-45.
Vaishali Veldurthy, Ran Wei, Leyla Oz, Puneet Dhawan, Yong Heui Jeon & Sylvia Christakos. Vitamin D, calcium homeostasis and aging. Bone Research. 2016. volume 4, Article number: 16041.
Altieri B., Grant W.B., Della Casa S., Orio F., Pontecorvi A., Colao A., Sarno G., Muscogiuri G. Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer. Crit. Rev. Food Sci. Nutr. 2017;57:3472–3488. doi: 10.1080/10408398.2015.1136922. [PubMed] [CrossRef] [Google Scholar]
Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metabolism. 2011;13(1):11–22. [PMC free article] [PubMed] [Google Scholar]
Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrology Dialysis Transplantation. 2006;21(4):889–897. [PubMed] [Google Scholar]
Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. European Journal of Immunology. 2006;36(2):361–370. [PubMed] [Google Scholar]
Candido FG, Bressan J. Vitamin D: link between osteoporosis, obesity and diabetes? Int J Mol Sci. 2014;15(4):6569–91.
Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E. Clinical implications of vitamin D deficiency. Prz Menopauzalny. 2015;14(2):75–81.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinology and Metabolism Clinics of North America. 2010;39(2):419–446. [PubMed] [Google Scholar]
Blanton D, Han Z, Bierschenk L, et al. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes. 2011;60(10):2566–2570. [PMC free article] [PubMed] [Google Scholar]
Farrokhian, A.; Raygan, F.; Bahmani, F.; Talari, H.R.; Esfandiari, R.; Esmaillzadeh, A.; Asemi, Z. Long-Term Vitamin D Supplementation Affects Metabolic Status in Vitamin D-Deficient Type 2 Diabetic Patients with Coronary Artery Disease. J. Nutr. 2017, 147, 384–389. [CrossRef]
Hurrle S., Hsu W.H. The etiology of oxidative stress in insulin resistance. Biomed. J. 2017;40:257–262. doi: 10.1016/j.bj.2017.06.007. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Newsholme P., Keane K.N., Carlessi R., Cruzat V. Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: Importance to cell metabolism, function, and dysfunction. Am. J. Physiol., Cell. Physiol. 2019;317:C420–C433.
Newsholme P., Cruzat V.F., Keane K.N., Carlessi R., de Bittencourt P.I.H. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem. J. 2016;473:4527–4550.
Izabela Szymczak-Pajor, Józef Drzewoski, Agnieszka Śliwińska. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020 Sep; 21(18): 6644.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sami A. Zbaar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.